$1.29
3.01% today
NYSE, Nov 20, 08:51 pm CET
ISIN
US35168W1036
Symbol
GUTS

Fractyl Health Stock price

$1.33
-0.06 4.32% 1M
-0.79 37.26% 6M
-0.73 35.44% YTD
-0.86 39.27% 1Y
-13.67 91.13% 3Y
-13.67 91.13% 5Y
-13.67 91.13% 10Y
-13.67 91.13% 20Y
NYSE, Closing price Wed, Nov 19 2025
-0.07 5.00%
ISIN
US35168W1036
Symbol
GUTS

Key metrics

Basic
Market capitalization
$182.3m
Enterprise Value
$190.0m
Net debt
$7.7m
Cash
$22.3m
Shares outstanding
49.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
9,113.5 | -
EV/Sales
9,498.0 | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
26.3%
Return on Equity
-247.8%
ROCE
-248.5%
ROIC
-
Debt/Equity
-1.6
Financials (TTM | estimate)
Revenue
$20.0k | $0.0
EBITDA
$-98.9m | $-104.3m
EBIT
$-99.8m | $-102.2m
Net Income
$-99.8m | $-75.8m
Free Cash Flow
$-82.3m
Growth (TTM | estimate)
Revenue
-83.3% | -100.0%
EBITDA
-39.2% | -12.3%
EBIT
-39.9% | -9.2%
Net Income
-51.4% | -7.6%
Free Cash Flow
-53.4%
Margin (TTM | estimate)
Gross
58.8%
EBITDA
-581,470.6% | -
EBIT
-587,305.9%
Net
-586,864.7% | -
Free Cash Flow
-484,370.6%
More
EPS
$-2.1
FCF per Share
$-1.6
Short interest
6.4%
Employees
103
Rev per Employee
$0.0
Show more

Is Fractyl Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Fractyl Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Fractyl Health forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Fractyl Health forecast:

Buy
91%
Hold
9%

Financial data from Fractyl Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
0.02 0.02
83% 83%
100%
- Direct Costs 0.01 0.01
86% 86%
50%
0.01 0.01
80% 80%
50%
- Selling and Administrative Expenses 20 20
3% 3%
99,900%
- Research and Development Expense 80 80
57% 57%
399,350%
-99 -99
39% 39%
-494,250%
- Depreciation and Amortization 0.99 0.99
168% 168%
4,950%
EBIT (Operating Income) EBIT -100 -100
40% 40%
-499,210%
Net Profit -100 -100
51% 51%
-498,850%

In millions USD.

Don't miss a Thing! We will send you all news about Fractyl Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fractyl Health Stock News

Neutral
Seeking Alpha
8 days ago
Fractyl Health, Inc. ( GUTS ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Brian Luque - Head of Investor Relations & Corporate Development Harith Rajagopalan - Co-Founder, CEO & Director Lisa Davidson - CFO & Treasurer Conference Call Participants Chi Meng Fong - BofA Securities, Research Division Michael DiFiore - Evercore ISI Institutional Equities, Research Divis...
Neutral
GlobeNewsWire
8 days ago
Positive randomized 3-month REMAIN-1 Midpoint Cohort data showed single Revita procedure maintained weight loss after GLP-1 discontinuation; 6-month data expected in Q1 2026 6-month data from open-label REVEAL-1 Cohort expected in Q4 2025 Topline 6-month data from REMAIN-1 Pivotal Cohort and potential PMA filing expected in H2 2026 $83M in underwritten offerings expected to extend cash runway t...
Neutral
GlobeNewsWire
15 days ago
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today announced it will report financial results for the third quarter 2025 and provide business updates on Wednesday, November 12, 2025, at 4:30 p.m. ET.
More Fractyl Health News

Company Profile

Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.

Head office United States
CEO Harith Rajagopalan
Employees 103
Founded 2010
Website www.fractyl.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today